These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 1968895
1. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. Eliakim R, Wengrower D, Ligumsky M, Rachmilewitz D. Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895 [No Abstract] [Full Text] [Related]
2. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Habal FM, Greenberg GR. Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391 [Abstract] [Full Text] [Related]
3. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group. Rutgeerts P. Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483 [Abstract] [Full Text] [Related]
4. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Andreoli A, Spinella S, Levenstein S, Prantera C. Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759 [Abstract] [Full Text] [Related]
5. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention. Sandborn WJ. Rev Gastroenterol Disord; 2006 Apr; 6(2):97-105. PubMed ID: 16699478 [Abstract] [Full Text] [Related]
6. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug 21; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]
7. Will there be a next generation of sulfasalazine? Goldman P. Gastroenterology; 1982 Nov 21; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related]
8. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J. Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):1012. PubMed ID: 6127137 [No Abstract] [Full Text] [Related]
9. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. d'Albasio G, Trallori G, Ghetti A, Milla M, Nucci A, Pacini F, Morettini A. Dis Colon Rectum; 1990 May 09; 33(5):394-7. PubMed ID: 1970284 [Abstract] [Full Text] [Related]
10. Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group. Rijk MC, van Lier HJ, van Tongeren JH. Am J Gastroenterol; 1992 Apr 09; 87(4):438-42. PubMed ID: 1348159 [Abstract] [Full Text] [Related]
11. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Rachmilewitz D. BMJ; 1989 Jan 14; 298(6666):82-6. PubMed ID: 2563951 [Abstract] [Full Text] [Related]
12. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study. d'Albasio G, Pacini F, Camarri E, Messori A, Trallori G, Bonanomi AG, Bardazzi G, Milla M, Ferrero S, Biagini M, Quaranta S, Amorosi A. Am J Gastroenterol; 1997 Jul 14; 92(7):1143-7. PubMed ID: 9219787 [Abstract] [Full Text] [Related]
13. Sulfasalazine and new analogues. Friedman G. Am J Gastroenterol; 1986 Feb 14; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
14. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis. Kruis W, Judmaier G, Kayasseh L, Stolte M, Theuer D, Scheurlen C, Hentschel E, Kratochvil P. Eur J Gastroenterol Hepatol; 1995 May 14; 7(5):391-6. PubMed ID: 7614099 [Abstract] [Full Text] [Related]
15. Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditis. LaRosa D, Rubin PH, Bodian C, Present DH. Am J Gastroenterol; 1991 Oct 14; 86(10):1456-60. PubMed ID: 1681725 [Abstract] [Full Text] [Related]
16. Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Dew MJ, Harries AD, Evans N, Evans BK, Rhodes J. Br Med J (Clin Res Ed); 1983 Jul 02; 287(6384):23-4. PubMed ID: 6134565 [No Abstract] [Full Text] [Related]
17. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage]. Bresci G, Carrai M, Venturini G, Gambardella L. Minerva Dietol Gastroenterol; 1990 Jul 02; 36(1):31-3. PubMed ID: 1970855 [Abstract] [Full Text] [Related]
19. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. Klotz U, Maier K, Fischer C, Heinkel K. N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853 [Abstract] [Full Text] [Related]
20. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE, Helmstädter V. Dtsch Med Wochenschr; 1986 May 02; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]